Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway-Reference-Cited by-同舟云学术

Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway

Published:2021-08 Issue: Volume:190 Page:114635
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Kwon Yun-Suk,Nam Kyung-Soo,Kim Soyoung

Funder

Kementerian Pendidikan Malaysia

Ministry of Health and Welfare

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference42 articles.

1. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy;Ross;Stem Cells,1998

2. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review;Carlsson;Br. J. Cancer,2004

3. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer;Vogel;J. Clin. Oncol.,2002

4. Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients;Petricevic;J. Transl. Med.,2013

5. Trastuzumab: updated mechanisms of action and resistance in breast cancer;Vu;Front. Oncol.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics and In Vitro Study Reveal ERα as The Potential Target Gene of Honokiol to Enhance Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer Cells;Computational Biology and Chemistry;2024-08

2. Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities;Biomedicine & Pharmacotherapy;2024-06

3. Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab;Breast Cancer: Targets and Therapy;2024-05

4. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics;Cancer and Metastasis Reviews;2024-03

5. Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines;International Journal of Molecular Sciences;2023-12-22